233 related articles for article (PubMed ID: 24776690)
1. The usefulness of preoperative 18FDG positron-emission tomography and computed tomography for predicting the malignant potential of gastrointestinal stromal tumors.
Tokumoto N; Tanabe K; Misumi T; Fujikuni N; Suzuki T; Ohdan H
Dig Surg; 2014; 31(2):79-86. PubMed ID: 24776690
[TBL] [Abstract][Full Text] [Related]
2. [The value of (18)F-FDG PET-CT imaging in predicting the malignant potential of GIST].
Li SX; Tang MD; Lin DY; Liu DJ; Lyu QH; Zhang JP; Cai ZH
Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):821-827. PubMed ID: 29151288
[No Abstract] [Full Text] [Related]
3. Gastric GIST malignancy evaluated by 18FDG-PET as compared with EUS-FNA and endoscopic biopsy.
Yamada M; Niwa Y; Matsuura T; Miyahara R; Ohashi A; Maeda O; Ando T; Ohmiya N; Itoh A; Hirooka Y; Goto H
Scand J Gastroenterol; 2007 May; 42(5):633-41. PubMed ID: 17454885
[TBL] [Abstract][Full Text] [Related]
4. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
[TBL] [Abstract][Full Text] [Related]
5. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
Xu XX; Cheng J; Xu WG; Dai D; Song XY; Ma WC; Zhu L; Zhu X
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458
[TBL] [Abstract][Full Text] [Related]
6. Role of FDG-PET/CT in evaluating surgical outcomes of operable breast cancer--usefulness for malignant grade of triple-negative breast cancer.
Ohara M; Shigematsu H; Tsutani Y; Emi A; Masumoto N; Ozaki S; Kadoya T; Okada M
Breast; 2013 Oct; 22(5):958-63. PubMed ID: 23756383
[TBL] [Abstract][Full Text] [Related]
7. Diffusion-weighted magnetic resonance imaging in metastatic gastrointestinal stromal tumor (GIST): a pilot study on the assessment of treatment response in comparison with 18F-FDG PET/CT.
Schmidt S; Dunet V; Koehli M; Montemurro M; Meuli R; Prior JO
Acta Radiol; 2013 Oct; 54(8):837-42. PubMed ID: 23761549
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic Features and Molecular Characteristics of Glucose Metabolism Contributing to ¹⁸F-fluorodeoxyglucose Uptake in Gastrointestinal Stromal Tumors.
Cho MH; Park CK; Park M; Kim WK; Cho A; Kim H
PLoS One; 2015; 10(10):e0141413. PubMed ID: 26509967
[TBL] [Abstract][Full Text] [Related]
9. Preoperative risk stratification using (18)F-FDG PET/CT in women with endometrial cancer.
Lee HJ; Ahn BC; Hong CM; Song BI; Kim HW; Kang S; Jeong SY; Lee SW; Lee J
Nuklearmedizin; 2011; 50(5):204-13. PubMed ID: 21727990
[TBL] [Abstract][Full Text] [Related]
10. Malignant diagnosis and prognostic analysis of 89 GIST patients using preoperative FDG-PET.
Narushima K; Shuto K; Okazumi S; Ohira G; Mori M; Hayano K; Yanagawa N; Matsubara H
Sci Rep; 2023 Feb; 13(1):2266. PubMed ID: 36755154
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of PET-CT for predicting the malignant potential of gastrointestinal stromal tumors.
Yoshikawa K; Shimada M; Kurita N; Sato H; Iwata T; Morimoto S; Miyatani T; Kashihara H; Takasu C; Matsumoto N
Surg Today; 2013 Oct; 43(10):1162-7. PubMed ID: 23143169
[TBL] [Abstract][Full Text] [Related]
12. Correlation of 18F-fluorodeoxyglucose uptake on positron emission tomography with Ki-67 index and pathological invasive area in lung adenocarcinomas 30 mm or less in size.
Murakami S; Saito H; Sakuma Y; Mizutani Y; Ishikawa Y; Kondou T; Oshita F; Yokose T; Kameda Y; Suga Y; Ito H; Tsuboi M; Nakayama H; Noda K; Yamada K
Eur J Radiol; 2010 Aug; 75(2):e62-6. PubMed ID: 20005653
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of dual-phase 18F-FDG PET/CT for diagnosing small pancreatic tumors.
Kawada N; Uehara H; Hosoki T; Takami M; Shiroeda H; Arisawa T; Tomita Y
Pancreas; 2015 May; 44(4):655-9. PubMed ID: 25815646
[TBL] [Abstract][Full Text] [Related]
14. Role of F-fluoro-2-deoxyglucose Positron Emission Tomography in Gastric GIST: Predicting Malignant Potential Pre-operatively.
Park JW; Cho CH; Jeong DS; Chae HD
J Gastric Cancer; 2011 Sep; 11(3):173-9. PubMed ID: 22076223
[TBL] [Abstract][Full Text] [Related]
15. Journal Club: Diagnostic value of (18)F-FDG PET/CT and MRI in predicting the clinicopathologic subtypes of invasive breast cancer.
Miyake KK; Nakamoto Y; Kanao S; Tanaka S; Sugie T; Mikami Y; Toi M; Togashi K
AJR Am J Roentgenol; 2014 Aug; 203(2):272-9. PubMed ID: 25055259
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of metabolic tumor volume assessed by 18F-FDG PET/CT added to SUVmax for characterization of thyroid 18F-FDG incidentaloma.
Kim BH; Kim SJ; Kim H; Jeon YK; Kim SS; Kim IJ; Kim YK
Nucl Med Commun; 2013 Sep; 34(9):868-76. PubMed ID: 23797273
[TBL] [Abstract][Full Text] [Related]
17. 18F-fluorodeoxyglucose positron emission tomography: useful technique for predicting malignant potential of gastrointestinal stromal tumors.
Kamiyama Y; Aihara R; Nakabayashi T; Mochiki E; Asao T; Kuwano H; Oriuchi N; Endo K
World J Surg; 2005 Nov; 29(11):1429-35. PubMed ID: 16222452
[TBL] [Abstract][Full Text] [Related]
18. Overestimated value of (18)F-FDG PET/CT to diagnose pulmonary nodules: Analysis of 298 patients.
Li S; Zhao B; Wang X; Yu J; Yan S; Lv C; Yang Y
Clin Radiol; 2014 Aug; 69(8):e352-7. PubMed ID: 24877581
[TBL] [Abstract][Full Text] [Related]
19. Role of combined 18F-FDG-PET/CT for predicting the WHO malignancy grade of thymic epithelial tumors: a multicenter analysis.
Lococo F; Cesario A; Okami J; Cardillo G; Cavuto S; Tokunaga T; Apolone G; Margaritora S; Granone P
Lung Cancer; 2013 Nov; 82(2):245-51. PubMed ID: 23992878
[TBL] [Abstract][Full Text] [Related]
20. Unusual loss of FDG uptake in recurrent GIST.
Dunzinger A; Decker J; Kieberger A; Weis S; Pichler R
Nuklearmedizin; 2014 Aug; 53(4):N35-7. PubMed ID: 25100559
[No Abstract] [Full Text] [Related]
[Next] [New Search]
